CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 15 enrolled
Drug / intervention
Magnetic Stimulator Rapid2 made by Magstim Company Ltd. U.K.device
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00699218
NCT00699218N/ACompleted
CompareCT.gov

A Pilot Study on Repetitive Transcranial Magnetic Stimulation (rTMS) for Treatment of Bipolar Depression

University of California, Davis·interventional·Posted Jun 17, 2008·Updated Jul 23, 2018

In Brief

A clinical study evaluating Magnetic Stimulator Rapid2 made by Magstim Company Ltd. U.K. for Mood Disorder and 3 related conditions. Completed, enrolled 15 participants across 1 site.

Detailed Summary

This is a pilot project to study if repetitive Transcranial Magnetic Stimulation (rTMS) will benefit patients with bipolar depression safely. Based on published studies, this study hypothesizes that rTMS on the left dorsal prefrontal lobe will improve symptoms in some patients who have failed at least two medications.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsMood Disorder, Bipolar Disorder, Major Depression, Depression
CountriesUnited States
CollaboratorsNational Alliance for Research on Schizophrenia and Depression

Timeline

N/ACompletedFinished
20082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedJun 17, 2008
Enrollment StartMay 1, 2008
Primary CompletionJul 1, 2009
Study CompletionApr 1, 2010
TodayJul 2, 2026
Enrollment to primary: 1.2 yearsPosted 18.0 years ago

Interventions

Magnetic Stimulator Rapid2 made by Magstim Company Ltd. U.K.device

High frequency repetitive TMS given daily on weekdays for 3 weeks